-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Ventyx Biosciences, Inc. quarterly and annual Nonoperating Income (Expense) history and change rate from Q3 2020 to Q3 2025.
- Ventyx Biosciences, Inc. Nonoperating Income (Expense) for the quarter ending 30 Sep 2025 was $2,045,000, a 38% decline year-over-year.
- Ventyx Biosciences, Inc. Nonoperating Income (Expense) for the twelve months ending 30 Sep 2025 was $10,115,000, a 27% decline year-over-year.
- Ventyx Biosciences, Inc. annual Nonoperating Income (Expense) for 2024 was $13,328,000, a 11% decline from 2023.
- Ventyx Biosciences, Inc. annual Nonoperating Income (Expense) for 2023 was $15,032,000, a 219% increase from 2022.
- Ventyx Biosciences, Inc. annual Nonoperating Income (Expense) for 2022 was $4,710,000.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Change (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Change (%)